Market Overview

Questcor Pharmaceuticals Fakeout A Breakout Over $27 Resistance Reaching $27.50 Highs Before Falling Back To $26.50 After Questcor's Acthar Gel Reapears on Kaiser Coverage List with No Restrictions

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: Technicals Trading Ideas

 

Related Articles (QCOR)

Around the Web, We're Loving...

Get Benzinga's Newsletters